Advertisement
Research Article| Volume 42, ISSUE 1, P67-96, July 1990

Download started.

Ok

Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids

  • Frank Z. Stanczyk
    Affiliations
    Department of Obstetrics and Gynecology University of Southern California School of Medicine Women's Hospital, Los Angeles County/USC Medical Center 1240 N. Mission Road, Los Angeles, California 90033 USA
    Search for articles by this author
  • Subir Roy
    Affiliations
    Department of Obstetrics and Gynecology University of Southern California School of Medicine Women's Hospital, Los Angeles County/USC Medical Center 1240 N. Mission Road, Los Angeles, California 90033 USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      There is limited information on the metabolism of levonorgestrel, norethindrone and structurally related contraceptive steroids. Both levonorgestrel and norethindrone undergo extensive reduction of the α,β-unsaturated ketone in ring A. Levonorgestrel also undergoes hydroxylation at carbons 2 and 16. The metabolites of both compounds circulate predominantly as sulfates. In urine, levonorgestrel metabolites are found primarily in the glucuronide form, whereas norethindrone metabolites are present in approximately equal amounts as sulfates and glucuronides. Of the progestogens structurally related to norethindrone, norethindrone acetate, ethynodiol diacetate, norethindrone enanthate, and perhaps lynestrenol, undergo rapid hydrolysis and are converted to the parent compound and its metabolites. There is no convincing evidence that norethynodrel is converted to norethindrone. Of the progestogens structurally related to levonorgestrel, it appears that neither desogestrel nor gestodene are transformed to the parent compound. However, there is evidence that norgestimate can be, at least partly, converted to levonorgestrel. Further studies on the metabolism of these progestogens are required before we can understand their mechanism of action.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith H
        • Hughes GA
        • Douglas GH
        • Hartley D
        • Mc Loughlin BJ
        • Siddall JB
        • Wendt GR
        • Buzby Jr, GC
        • Herbst DR
        • Ledig KW
        • McMenamin JR
        • Pattison TW
        • Suida J
        • Tokalics J
        • Edgren RA
        • Jansen ABA
        • Gadsby B
        • Watson DHR
        • Phillips PC
        Totally synthetic (±)-13-alkyl-3-hydroxy and methoxy-gona-l,3,5(10)-trien-17-ones and related compounds.
        Experientia. 1963; 19: 394-396
        • Edgren RA
        • Smith H
        • Hughes GA
        • Smith LL
        • Greenspan G
        Biological effects of racemic and resolved 13β-ethyl-4-gonen-3-ones.
        Steroids. 1963; 2: 731-737
        • Jones RC
        • Singer AC
        • Edgren RA
        The biological activities of norgestrel and its enantiomers.
        Int J Fertil. 1979; 24: 39-43
        • Lardon A
        • Schindler O
        • Reichstein T
        Eine weitere synthese von d, l-aldosteron.
        Helv. Chim. Acta. 1957; 40: 676-677
        • Fieser LF
        • Fieser M
        2nd ed. Steroids. Reinhold Publishing Corporation, New York1959: 336
        • IUPAC Commission on the Nomenclature of Organic Chemistry
        • IUPAC-IUB Commission on Biochemical Nomenclature
        Revised tentative rules for nomenclature of steroids.
        Steroids. 1969; 13: 277-310
      1. WHO Chronicle, Supplement. 1975; Vol. 29: 26
        • Sisenwine SF
        • Kimmel HB
        • Liu AL
        • Ruelius HW
        The presence of DL-, D-, and L-norgestrel and their metabolites in the plasma of women.
        Contraception. 1975; 12: 339-353
        • Sisenwine SF
        • Kimmel HB
        • Liu AL
        • Ruelius HW
        Excretion and stereoselective biotransformations of dl- d- and 1- norgestrel in women.
        Drug Metabol Disp. 1975; 3: 180-188
        • Sisenwine SF
        • Kimmel HB
        • Liu AL
        • Ruelius HW
        Urinary metabolites of DL-norgestrel in women.
        Acta Endocrinol. 1973; 73: 91-104
        • Littleton P
        • Fotherby K
        • Dennis KJ
        Metabolism of [14C]norgestrel in man.
        J Endocrinol. 1968; 42: 591-598
        • DeJongh DC
        • Hribar JD
        • Littleton P
        • Fortherby K
        • Rees RWA
        • Shrader S
        • Foell TJ
        • Smith H
        The identification of some human metabolites of norgestrel, a new progestational agent.
        Steroids. 1968; 11: 649-666
        • Gerhards E
        • Hecher W
        • Hitze H
        • Nieuweboer B
        • Bellmann O
        Zum stoffwechsel von norethisteron (17α-athinyl-4-ostren-17β-ol-3-on) und DL-sowie D-norgestrel (18-methyl-17α-athinyl-4-estren-17β-ol-3-on) beim menschen.
        Acta Endocrinol. 1971; 68: 219-248
        • Layne DS
        • Golab T
        • Arai K
        • Pincus G
        The metabolic fate of orally administered 3H-norethynodrel and 3H-norethindrone in humans.
        Biochem Pharmacol. 1963; 12: 905-911
        • Fotherby K
        • Kamyab S
        • Littleton P
        • Klopper AI
        Metabolism of synthetic progestational compounds in humans.
        J Reprod Fertil Suppl 5. 1968; : 51-61
        • Kamyab S
        • Fotherby K
        • Klopper AI
        Metabolism of [4-14C] norethisterone in women.
        J Endocrinol. 1968; 41: 263-272
        • Braselton WE
        • Lin TJ
        • Mills TM
        • Ellegood JO
        • Mahesh VB
        Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood.
        J Steroid Biochem. 1977; 8: 9-18
        • Murata S
        Metabolism of 17α-ethynyl-19-nortestosterone and 17α-ethinylestrenol in vivo.
        Folia Endocrinol Jpn. 1968; 43: 1083-1096
        • Stillwell WG
        • Horning EC
        • Horning MG
        • Stillwell RN
        • Zlatkis A
        Characterization of metabolites of steroid contraceptives by gas chromatography and mass spectrometry.
        J Steroid Biochem. 1972; 3: 699-706
        • Fotherby K
        • Kamyab S
        • Littleton P
        • Klopper AI
        Metabolism of 17α-ethynyl steroids.
        Biochem J. 1966; 99: 14
        • Breuer H
        • Dardenne U
        • Nocke W
        Ausscheidung von 17-Ketosteroiden, 17-ketogenen steroiden und ostrogenen beim menschen nach gaben von 17α-athynyl-19-nortestosteron-estern.
        Acta Endocrinol. 1960; 33: 10-26
        • Brown JB
        • Blair HAF
        Urinary oestrogen metabolites of 19-norethisterone and its esters.
        in: 2nd ed. Proc Roy Soc Med. 53. 1960: 433
        • Kaiser R
        • Stecher H
        Die bieinflussung der oestrogen-ausscheidung durch unveresterte und veresterte 19-nortestosteronverbindungen.
        Arch Gynak. 1960; 194: 146-157
        • Langecker H
        Die metabolite im menschlichen harn nach verabreichung von 17α-aethinyl-19-nortestosteron (Noraethisteron).
        Acta Endocrinol. 1961; 37: 14-18
        • Okada H
        • Amatsu M
        • Ishihara S
        • Tokuda G
        Conversion of some synthetic progestins to oestrogens.
        Acta Endocrinol. 1964; 46: 31-36
        • Breuer H
        Metabolism of progestagens.
        Lancet. 1970; 2: 615-616
        • Townsley JD
        • Possanza G
        • Brodie HJ
        A new placental metabolite of oestr-4-ene-3,17-dione: a possible source of error in oestrogen estimation.
        Biochem J. 1966; 101: 25c-27c
        • Townsley JD
        • Brodie HJ
        Studies on the mechanism of estrogen biosynthesis. IV. Ovarian metabolism of estr-4-ene-3, 17-dione.
        Biochim Biophys Acta. 1967; 144: 440-445
        • Edgren RA
        • Peterson DL
        • Jones RC
        Some progestational and antifertility effects of norgestrel.
        Internal J Fertil. 1966; : 389-400
        • McPherson III, JC
        • Costoff A
        • Elridge JC
        • Mahesh VB
        Effect of various progestational preparations on gonadotropin secretion in ovariectomized immmature female rats.
        Fertil Steril. 1974; 25: 1063-1072
        • Yamamoto T
        • Yoshiji S
        • Yasuda J
        • Shiroshita K
        • Kitawaki J
        • Fujii M
        • Urabe M
        • Honjo H
        • Okada H
        Aromatization of norethindrone to ethynylestradiol in human adult liver.
        Endocrinol Japon. 1986; 33: 527-531
        • Vinikka L
        • Ylikorkala O
        • Vihko R
        • Wijnand HP
        • Booij M
        • van der Veen F
        Metabolism of a new synthetic progestogen, ORG 2969, in female volunteers. Pharmacokinetics after an oral dose.
        Europ J Clin Pharmacol. 1979; 15: 349-355
        • Hasenack HG
        • Bosch AMG
        • Kaar K
        Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel.
        Contraception. 1986; 33: 591-596
        • Viinikka L
        Metabolism of a new synthetic progestogen, ORG 2969, by human liver in vitro.
        J Steroid Biochem. 1979; 10: 353-357
        • Dusterberg B
        • Tack J-W
        • Krause W
        • Humpel M
        Pharmacokinetics and biotransformation of gestodene in man.
        in: Elstein M Gestodene, development of a new gestodene-containing low-dose oral contraceptive. Parthenon Publishers, England1987: 35-44
        • Alton KB
        • Hetyel NS
        • Shaw C
        • Patrick JE
        Biotransformation of norgestimate in women.
        Contraception. 1984; 29: 19-29
        • Chapdelaine A
        • Desmarais J-L
        • Derman RJ
        Clinical evidence for the minimal androgenic activity of norgestimate.
        Intl J Fertil. 1989; 34: 347-352
        • Phillips A
        • Demarest K
        • Hahn DW
        • Wong F
        • McGuire JL
        Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
        Contraception. 1990; 41: 399-410
        • Cook CE
        • Twine ME
        • Tallent CR
        • Wall ME
        • Bressler RC
        Norethynodrel metabolites in human plasma and urine.
        J Pharmacol Exp Ther. 1972; 183: 197-205
        • McGinty DA
        • Djerrassi C
        Some chemical and biological properties of 19-nor-17α-ethynyltestosterone.
        Ann. N.Y. Acad Sci. 1958; 71: 500-515
        • Arai K
        • Golab T
        • Layne DS
        • Pincus G
        Metabolic fate of orally administered 3H-norethynodrel in rabbits.
        Endocrinol. 1962; 71: 639-648
        • Layne DS
        • Golab T
        • Arai K
        • Pincus G
        The metabolic fate of orally administered 3H-norethynodrel and 3H-norethindrone in humans.
        Biochem Pharmacol. 1963; 12: 905-911
        • Palmer KH
        • Ross FT
        • Rhodes S
        • Baggett B
        • Wall ME
        Metabolism of antifertility steroids. 1. Norethynodrel.
        J Pharmacol Exp Ther. 1969; 167: 207-216
        • Freudenthal RI
        • Cook CE
        • Twine M
        • Rosenfeld R
        • Wall ME
        Metabolism of norethynodrel by rat liver.
        Biochem Pharmacol. 1971; 20: 1507-1512
        • Murugesan K
        • Hingorani V
        • Laumas KR
        In vitro metabolism of [6, 7-3H]-norethynodrel in the human endometrium and myometrium.
        Acta Endocrinol. 1973; 74: 576-591
        • Kishimoto Y
        • Kraychy S
        • Ranney RE
        • Zitzewitz DJ
        • Gantt CL
        Metabolism of oral contraceptives II. Metabolism of norethynodrel in women.
        Xenobiotica. 1972; 2: 253-258
        • Cook CE
        • Karim A
        • Forth J
        • Wall ME
        • Ranney RE
        • Bressler RC
        Ethynodiol diacetate metabolites in human plasma.
        J Pharacol Exp Ther. 1973; 185: 696-702
        • Kishimoto Y
        • Kraychy S
        • Ranney RE
        • Gantt CL
        Metabolism of oral contraceptives. I. Metabolism of ethynodiol diacetate in women.
        Xenobiotica. 1972; 2: 237-252
        • Singh H
        • Uniyal JP
        • Jha P
        • Murugesan K
        • Takkar D
        • Hingorani V
        • Laumas KR
        Pharmacokinetics of norethindrone acetate in women.
        Am J Obstet Gynecol. 1979; 135: 409-414
        • Sarkar NN
        • Laumas V
        • Agarwal N
        • Hingorani V
        • Laumas KR
        Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
        Acta Obstet Gynecol Scand. 1983; 62: 71-76
        • Kamyab S
        • Fortherby K
        • Klopper AI
        Metabolism of [4-14C]-lynestrenol in man.
        J Endocrinol. 1968; 42: 337-343
        • Odlind V
        • Weiner E
        • Victor A
        • Johansson EDB
        Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol.
        Clin Endocrinol. 1979; 10: 29-38
        • Howard G
        • Khan FS
        • Warren RJ
        • Fotherby K
        Metabolism of norethisterone enanthate in vivo and in vitro.
        J Endocrinol. 1975; 65: 20P-21P
        • Howard G
        • Warren RJ
        • Fotherby K
        Plasma levels of norethisterone in women receiving norethisterone oenanthate intramuscularly.
        Contraception. 1975; 12: 45-52
        • Gerhards E
        • Hecher W
        • Bellmann O
        Studies on the kinetics and metabolism of 17β-heptanoyl-17α-ethinyl-4-oestren-3-one-73H (norethisterone enanthate) in humans following intramuscular injection.
        Arzneim-Forsch (Drug Res). 1976; 26: 1611-1614
        • Goebelsmann U
        • Stanczyk FZ
        • Brenner PF
        • Goebelsmann AE
        • Gentzschein EKE
        • Mishell Jr., DR
        Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
        Contraception. 1979; 19: 283-313
        • Saxena BN
        • Shrimanker K
        • Fotherby K
        Radioimmunoassay of serum norethisterone oenanthate levels in women after intramuscular administration.
        J Steroid Biochem. 1977; 8: 1117-1119